
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz - 2
Child influencers helped power a booming industry. It's time for a reckoning. - 3
Ministry: New German petrol price regulation takes effect on April 1 - 4
Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara - 5
'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
Oil Tanker Carrying Iraqi Cargo Seen Transiting Strait of Hormuz
Hoist Your Style: Famous Hairdos for Ladies
Evidence of lost baptismal rite stage uncovered in Byzantine era cathedral near Sea of Galilee
9 Under-The-Radar Malaysian Islands To Consider Instead Of Thailand Or Indonesia
Israel faces tough choices over haredi draft exemptions, legal expert warns
Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
'Euphoria' Season 3 trailer includes Eric Dane's final appearance, Jacob Elordi and Sydney Sweeney at the altar and Zendaya's 'Breaking Bad' era
They died 'doing what they loved': The stories of workers in their 80s who died on the job
Best Disney Palace: Which One Catches Your Creative mind?













